Neuroimaging in Cerebellar Ataxias: A Diagnostic Approach
- PMID: 40940580
- DOI: 10.1007/s12311-025-01908-w
Neuroimaging in Cerebellar Ataxias: A Diagnostic Approach
Abstract
Ataxias are a group of neurologic disorders, with heterogeneous clinical and genetic presentation and with a challenging diagnostic approach that navigates through the neuroimage field. Typical clinical features of ataxias include variable degrees of cerebellar ataxia, as a pure clinical picture or associated with other neurologic or extra neurological symptoms (cognitive impairment, epilepsy, other movement disorders, abnormal ocular movements, systemic symptoms). Neuroimaging plays an important role in the characterization of patients with ataxia. Despite the development of genetics and neuroimaging, some cases remain with no diagnosis. This review proposes a didactic investigation approach for ataxias based on three main magnetic resonance imaging features: a) ataxias without cerebellar atrophy; b) ataxias with pure cerebellar atrophy or olivopontocerebellar atrophy; and c) ataxias with specific imaging features. A comprehensive review of peer-reviewed articles on neuroimaging in diseases associated with cerebellar ataxia was conducted through a search in PubMed and SciELO. For each topic, we discuss the possible diagnosis and suggest a guided investigation. The classification of cerebellar ataxias into distinct categories-based on the presence or absence of cerebellar atrophy and specific neuroradiological features-profoundly enhances the diagnostic approach to these complex disorders.
Keywords: Cerebellar ataxia; Cerebellum; Neurogenetics; Neuroimage.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical approval: The authors confirm that the approval of an institutional review board and obtention of informed consent were not required for this work. We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. Competing interests: Alex Meira has received honoraria from Abbvie, Aché, Ipsen, Teva Pharmaceuticals and Zambon and travel grants from Boston Scientific, FQM, Ipsen. Thiago Vale has received honoraria from FQM, Abbvie and Teva Pharmaceuticals and grants from the International Parkinson and Movement Disorders Society for the past 12 months. Marcondes França Jr has participated in clinical trials from PTC and Biogen and received honoraria from Biogen. Sophia da Costa, Claudie Gauvreau, Camila Piccinin, Hélio Teive, Nicolas Dupré, Orlando Barsottini and José Luiz Pedroso declare that there are no additional disclosures to report. Clinical Trial Number: Not applicable.
References
-
- Rosenthal LS. Neurodegenerative cerebellar ataxia. Continuum Lifelong Learn Neurol. 2022;28(5):1409–34. https://doi.org/10.1212/CON.0000000000001180 . - DOI
-
- Beaudin M, Klein CJ, Rouleau GA, et al. Systematic review of autosomal recessive ataxias and proposal for a classification. Cerebellum Ataxias. 2017;4(1): 3. https://doi.org/10.1186/s40673-017-0061-y . - DOI - PubMed - PMC
-
- Raslan IR, Barsottini OG, Pedroso JL. A proposed clinical classification and a diagnostic approach for congenital ataxias. Neur Clin Pract. 2021;11(3):e328–36. https://doi.org/10.1212/CPJ.0000000000000966 . - DOI
-
- Nachbauer W, Eigentler A, Boesch S. Acquired ataxias: the clinical spectrum, diagnosis and management. J Neurol. 2015;262(5):1385–93. https://doi.org/10.1007/s00415-015-7685-8 . - DOI - PubMed
-
- Coarelli G, Wirth T, Tranchant C, et al. The inherited cerebellar ataxias: an update. J Neurol. 2023;270(1):208–22. https://doi.org/10.1007/s00415-022-11383-6 . - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
